Can a simple protein test predict heart trouble in breast cancer patients?
NCT ID NCT06443645
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a protein called SGLT2 is linked to heart damage caused by a common type of breast cancer chemotherapy. Researchers will measure SGLT2 levels in blood and cells from 50 women with localized breast cancer before and after treatment. The goal is to find better ways to identify who is at risk for heart problems, so doctors can prevent them in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Paul Strauss
RECRUITINGStrasbourg, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smartwatch could spot nerve damage before it starts
- Can acupuncture soothe the mind and body in breast cancer?
- CT scans may predict breast reconstruction flap failure
- A gentle jog might be the key to better sleep for breast cancer survivors
- Peer power: could community education boost cancer screening?
- Robotic vs. endoscopic: which biopsy method is more accurate for breast cancer?